Epigenetic modifications in vitamin D Receptor-mediated transrepression

Vitamin D

Volumn , Issue , 2011, Pages 227-234

  Kouzmenko, Alexander ^a,b   Ohtake, Fumiaki ^a   Fujiki, Ryoji ^a   Kato, Shigeaki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b ALFAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862681743     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-381978-9.10012-5     Document Type: Chapter

References (50)

1. DeLuca H.F. Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 2004, 80(Suppl.):1689S-1696S.
2. Dusso A.S., Brown A.J., Slatopolsky E. Vitamin D. Am. J. Physiol. Renal. Physiol. 2005, 289:F8-28.
3. Adorini L., Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat. Clin. Pract. Rheumatol. 2008, 4:404-412.
4. Szatmari I., Nagy L. Nuclear receptor signalling in dendritic cells connects lipids, the genome and immune function. EMBO J. 2008, 27:2353-2362.
5. Takeyama K., Kitanaka S., Sato T., Kobori M., Yanagisawa J., Kato S. 25-Hydroxyvitamin D3 1α-hydroxylase and vitamin D synthesis. Science 1997, 277:1827-1830.
6. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., et al. The nuclear receptor superfamily: the second decade. Cell 1995, 83:835-839.
7. Yoshizawa T., Handa Y., Uematsu Y., Takeda S., Sekine K., Yoshihara Y., et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat. Genet. 1997, 16:391-396.
8. Kato S., Yoshizazawa T., Kitanaka S., Murayama A., Takeyama K. Molecular genetics of vitamin D-dependent hereditary rickets. Horm. Res. 2002, 57:73-78.
9. Bouillon R., Carmeliet G., Verlinden L., van Etten E., Verstuyf A., Luderer H.F., et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev. 2008, 29:726-776.
10. McCullough M.L., Bostick R.M., Mayo T.L. Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer. Annu. Rev. Nutr. 2009, 29:111-132.
11. Haussler M.R., Haussler C.A., Bartik L., Whitfield G.K., Hsieh J.C., Slater S., et al. Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutr. Rev. 2008, 66(Suppl. 2):S98-112.
12. Rachez C., Lemon D., Suldan Z., Bromleigh V., Gamble M., Naar M., et al. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 1999, 398:824-828.
13. Glass C.K., Rosenfeld M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 2000, 14:121-141.
14. Kitagawa H., Fujiki R., Yoshimura K., Mezaki Y., Uematus Y., Matsui D., et al. The chromatin remodeling complex WINAC targets a nuclear receptor to promoters and is impaired in Williams Syndrome. Cell 2003, 113:1-13.
15. Murayama A., Kim M.S., Yanagisawa J., Takeyama K., Kato S. Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching. EMBO J. 2004, 23:1598-1608.
16. Narlikar G.J., Fan H.Y., Kingston R.E. Cooperation between complexes that regulate chromatin structure and transcription. Cell 2002, 108:475-487.
17. Waga S., Stillman B. The DNA replication fork in eukaryotic cells. Annu. Rev. Biochem. 1998, 67:721-751.
18. Reinberg D., Sims R.J. de FACTo nucleosome dynamics. J. Biol. Chem. 2006, 281:23297-23301.
19. Ransom M., Dennehey B.K., Tyler J.K. Chaperoning histones during DNA replication and repair. Cell 2010, 140:183-195.
20. Fujiki R., Kim M.S., Sasaki Y., Yoshimura K., Kitagawa H., Kato S. Ligand-induced transrepression by VDR through association of WSTF with acetylated histones. EMBO J. 2005, 24:3881-3894.
21. Meyer M.B., Watanuki M., Kim S., Shevde N.K., Pike J.W. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells. Mol. Endocrinol. 2006, 20:1447-1461.
22. Alroy I., Towers T.L., Freedman L.P. Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol. Cell Biol. 1995, 15:5789-5799.
23. Demay M.B., Kiernan M.S., DeLuca H.F., Kronenberg H.M. Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3. Proc. Natl. Acad. Sci. USA 1992, 89:8097-8101.
24. Falzon M. DNA sequences in the rat parathyroid hormone related peptide gene responsible for 1,25-dihydroxyvitamin D3-mediated transcriptional repression. Mol. Endocrinol. 1996, 10:672-681.
25. Russell J., Ashok S., Koszewski N.J. Vitamin D receptor interactions with the rat parathyroid hormone gene: synergistic effects between two negative vitamin D response elements. J. Bone Miner. Res. 1999, 14:1828-1837.
26. Kim M.S., Fujiki R., Murayama A., Kitagawa H., Yamaoka K., Yamamoto Y., et al. 1a,25(OH)2D3-induced transrepression by vitamin D receptor through E-box-type elements in the human parathyroid hormone gene promoter. Mol. Endocrinol. 2007, 21:334-342.
27. Henry H.L. Parathyroid hormone modulation of 25-hydroxyvitamin D3 metabolism by cultured chick kidney cells is mimicked and enhanced by forskolin. Endocrinology 1985, 116:503-510.
28. McNamara P., Seo S.B., Rudic R.D., Sehgal A., Chakravarti D., FitzGerald G.A. Regulation of CLOCK and MOP4 by nuclear hormone receptors in the vasculature: a humoral mechanism to reset a peripheral clock. Cell 2001, 105:877-889.
29. Xu W., Chen H., Du K., Asahara H., Tini M., Emerson B.M., et al. A transcriptional switch mediated by cofactor methylation. Science 2001, 294:2507-2511.
30. Kato S., Fujiki R., Kitagawa H. Vitamin D receptor (VDR) promoter targeting through a novel chromatin remodeling complex. J. Steroid Biochem. Mol. Biol. 2004, 89-90:173-178.
31. Kim M.S., Kondo T., Takada I., Youn M.Y., Yamamoto Y., Takahashi S., et al. DNA demethylation in hormone-induced transcriptional derepression. Nature 2009, 461:1007-1012.
32. Okano M., Bell D.W., Haber D.A., Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999, 99:247-257.
33. Howell C.Y., Bestor T.H., Ding F., Latham K.E., Mertineit C., Trasler J.M., et al. Genomic imprinting disrupted by a maternal effect mutation in the Dnmt1 gene. Cell 2001, 104:829-838.
34. Rhee I., Bachman K.E., Park B.H., Jair K.W., Yen R.W., Schuebel K.E., et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 2002, 416:552-556.
35. Maison C., Almouzni G. HP1 and the dynamics of heterochromatin maintenance. Nat. Rev. Mol. Cell Biol. 2004, 5:296-304.
36. Probst A.V., Dunleavy E., Almouzni G. Epigenetic inheritance during the cell cycle. Nat. Rev. Mol. Cell Biol. 2009, 10:192-206.
37. Simonsson S., Gurdon J. DNA demethylation is necessary for the epigenetic reprogramming of somatic cell nuclei. Nat. Cell Biol. 2004, 6:984-990.
38. Moss T.J., Wallrath L.L. Connections between epigenetic gene silencing and human disease. Mutat. Res. 2007, 618:163-174.
39. Zhu J.K. Active DNA demethylation mediated by DNA glycosylases. Annu. Rev. Genet. 2009, 43:143-166.
40. Métivier R., Gallais R., Tiffoche C., Le Péron C., Jurkowska R.Z., Carmouche R.P., et al. Cyclical DNA methylation of a transcriptionally active promoter. Nature 2008, 452:45-50.
41. S. Kangaspeska, B. Stride, R. Métivier, M. Polycarpou-Schwarz, D. Ibberson, R.P. Carmouche, et al., Transient cyclical methylation of promoter DNA, Nature 452 112-5.
42. Métivier R., Penot G., Hübner M.R., Reid G., Brand H., Kos M., et al. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 2003, 115:751-763.
43. Métivier R., Huet G., Gallais R., Finot L., Petit F., Tiffoche C., et al. Dynamics of estrogen receptor-mediated transcriptional activation of responsive genes in vivo: apprehending transcription in four dimensions. Adv. Exp. Med. Biol. 2008, 617:129-138.
44. Hendrich B., Bird A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell Biol. 1998, 18:6538-6547.
45. Hendrich B., Hardeland U., Ng H.H., Jiricny J., Bird A. The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature 1999, 401:301-304.
46. Kondo E., Gu Z., Horii A., Fukushige S. The thymine DNA glycosylase MBD4 represses transcription and is associated with methylated p16(INK4a) and hMLH1 genes. Mol. Cell Biol. 2005, 25:4388-4396.
47. Rai K., Huggins I.J., James S.R., Karpf A.R., Jones D.A., Cairns B.R. DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and gadd45. Cell 2008, 135:1201-1212.
48. Demple B., Sung J.S. Molecular and biological roles of Ape1 protein in mammalian base excision repair. DNA Repair 2005, 4:1442-1449.
49. David S.S., O'Shea V.L., Kundu S. Base-excision repair of oxidative DNA damage. Nature 2007, 447:941-945.
50. Lee M., Partridge N.C. Parathyroid hormone signaling in bone and kidney. Curr. Opin. Nephrol. Hypertens. 2009, 18:298-302.